Diabetes Drugs Evaluated by FDA for Pancreatic Cancer Risk

Diabetes Drugs Evaluated by FDA for Pancreatic Cancer Risk

Hannelore Foerster/Bloomberg

Merck & Co., the second-largest U.S. drugmaker, reported $4 billion in sales, or about 9 percent of total revenue, from Januvia last year.